Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 59 |
| List of Tables | 52 | 8 |
| List of Figures | 60 | 1 |
| Introduction | 61 | 1 |
| Global Markets Direct Report Coverage | 61 | 1 |
| Rheumatoid Arthritis Overview | 62 | 1 |
| Therapeutics Development | 63 | 2 |
| Pipeline Products for Rheumatoid Arthritis Overview | 63 | 1 |
| Pipeline Products for Rheumatoid Arthritis Comparative Analysis | 64 | 1 |
| Rheumatoid Arthritis Therapeutics under Development by Companies | 65 | 18 |
| Rheumatoid Arthritis Therapeutics under Investigation by Universities/Institutes | 83 | 3 |
| Rheumatoid Arthritis Pipeline Products Glance | 86 | 4 |
| Late Stage Products | 86 | 1 |
| Clinical Stage Products | 87 | 1 |
| Early Stage Products | 88 | 1 |
| Unknown Stage Products | 89 | 1 |
| Rheumatoid Arthritis Products under Development by Companies | 90 | 28 |
| Rheumatoid Arthritis Products under Investigation by Universities/Institutes | 118 | 3 |
| Rheumatoid Arthritis Companies Involved in Therapeutics Development | 121 | 222 |
| 3SBio Inc. | 121 | 1 |
| 4D Pharma Plc | 122 | 1 |
| 4SC AG | 123 | 1 |
| AB Science SA | 124 | 1 |
| AB2 Bio Ltd. | 125 | 1 |
| AbbVie Inc. | 126 | 1 |
| Ablynx NV | 127 | 1 |
| ACEA Biosciences, Inc. | 128 | 1 |
| Addex Therapeutics Ltd | 129 | 1 |
| Advinus Therapeutics Ltd | 130 | 1 |
| AlphaMab Co., Ltd | 131 | 1 |
| Alteogen Inc. | 132 | 1 |
| Amgen Inc. | 133 | 1 |
| Amura Holdings Limited | 134 | 1 |
| Anacor Pharmaceuticals, Inc. | 135 | 1 |
| Applied Genetic Technologies Corporation | 136 | 1 |
| ARA Healthcare Pvt. Ltd. | 137 | 1 |
| Arena Pharmaceuticals, Inc. | 138 | 1 |
| Arrien Pharmaceuticals, LLC | 139 | 1 |
| Arthrogen BV | 140 | 1 |
| Asahi Kasei Pharma Corp. | 141 | 1 |
| Asana BioSciences, LLC | 142 | 1 |
| Astellas Pharma Inc. | 143 | 1 |
| AstraZeneca Plc | 144 | 1 |
| Avexxin AS | 145 | 1 |
| Axxam SpA | 146 | 1 |
| BCN Peptides, S.A. | 147 | 1 |
| Bio-Cancer Treatment International Limited | 148 | 1 |
| BIOCAD | 149 | 1 |
| Biocon Limited | 150 | 1 |
| Biokine Therapeutics Ltd. | 151 | 1 |
| BioLingus AG | 152 | 1 |
| BioLite, Inc. | 153 | 1 |
| Bionovis SA | 154 | 1 |
| BioTherapeutics Inc. | 155 | 1 |
| Bird Rock Bio, Inc. | 156 | 1 |
| Boehringer Ingelheim GmbH | 157 | 1 |
| Bone Medical Limited | 158 | 1 |
| Boryung Pharmaceutical Co., Ltd. | 159 | 1 |
| Bristol-Myers Squibb Company | 160 | 1 |
| Can-Fite BioPharma Ltd. | 161 | 1 |
| Cardax Pharmaceuticals, Inc. | 162 | 1 |
| CASI Pharmaceuticals Inc. | 163 | 1 |
| CEL-SCI Corporation | 164 | 1 |
| Celgene Corporation | 165 | 1 |
| Cellceutix Corporation | 166 | 1 |
| Celltrion, Inc. | 167 | 1 |
| ChemoCentryx, Inc. | 168 | 1 |
| Chipscreen Biosciences Ltd | 169 | 1 |
| ChironWells GmbH | 170 | 1 |
| Chong Kun Dang Pharmaceutical Corp. | 171 | 1 |
| CJ HealthCare Corp. | 172 | 1 |
| CLL Pharma | 173 | 1 |
| Clonz Biotech Private Limited | 174 | 1 |
| Coherus BioSciences, Inc. | 175 | 1 |
| Commence Bio, Inc. | 176 | 1 |
| Compugen Ltd. | 177 | 1 |
| Confluence Life Sciences, Inc. | 178 | 1 |
| CSL Limited | 179 | 1 |
| Cyclacel Pharmaceuticals, Inc. | 180 | 1 |
| Daiichi Sankyo Company, Limited | 181 | 1 |
| Diamyd Medical AB | 182 | 1 |
| Domainex Limited | 183 | 1 |
| Dr. Reddy's Laboratories Limited | 184 | 1 |
| Eisai Co., Ltd. | 185 | 1 |
| Eli Lilly and Company | 186 | 1 |
| Enceladus Pharmaceuticals BV | 187 | 1 |
| Endocyte, Inc. | 188 | 1 |
| Enzene Biosciences Ltd. | 189 | 1 |
| Epirus Biopharmaceuticals, Inc. | 190 | 1 |
| F. Hoffmann-La Roche Ltd. | 191 | 1 |
| Five Prime Therapeutics, Inc. | 192 | 1 |
| Fountain Biopharma Inc. | 193 | 1 |
| Galapagos NV | 194 | 1 |
| Gene Techno Science Co., Ltd. | 195 | 1 |
| Genentech, Inc. | 196 | 1 |
| Genor BioPharma Co., Ltd. | 197 | 1 |
| Genosco | 198 | 1 |
| Gilead Sciences, Inc. | 199 | 1 |
| GlaxoSmithKline Plc | 200 | 1 |
| Griffin Discoveries BV | 201 | 1 |
| Han Wha Pharma Co., Ltd. | 202 | 1 |
| Handok Inc. | 203 | 1 |
| Hanmi Pharmaceuticals, Co. Ltd. | 204 | 1 |
| Hansa Medical AB | 205 | 1 |
| Hanwha Chemical Corporation | 206 | 1 |
| HEC Pharm Co., Ltd. | 207 | 1 |
| Hetero Drugs Limited | 208 | 1 |
| HitGen LTD | 209 | 1 |
| Huabo Biopharm Co., Ltd. | 210 | 1 |
| Hutchison MediPharma Limited | 211 | 1 |
| Idera Pharmaceuticals, Inc. | 212 | 1 |
| Idogen AB | 213 | 1 |
| Immune Response BioPharma, Inc. | 214 | 1 |
| Immungenetics AG | 215 | 1 |
| ImmunoFrontier, Inc. | 216 | 1 |
| Innate Pharma S.A. | 217 | 1 |
| Innovent Biologics, Inc. | 218 | 1 |
| Intas Pharmaceuticals Ltd. | 219 | 1 |
| ISU ABXIS Co.,Ltd. | 220 | 1 |
| JHL Biotech, Inc. | 221 | 1 |
| Jiangsu Hengrui Medicine Co., Ltd. | 222 | 1 |
| Johnson &Johnson | 223 | 1 |
| Jyant Technologies, Inc. | 224 | 1 |
| Kadmon Corporation, LLC | 225 | 1 |
| KAHR medical Ltd. | 226 | 1 |
| Kang Stem Biotech Co., Ltd. | 227 | 1 |
| Karus Therapeutics Limited | 228 | 1 |
| Karyopharm Therapeutics, Inc. | 229 | 1 |
| Kezar Life Sciences, Inc. | 230 | 1 |
| Kineta, Inc. | 231 | 1 |
| Kolltan Pharmaceuticals, Inc. | 232 | 1 |
| Lead Pharma Holding B.V. | 233 | 1 |
| Lexicon Pharmaceuticals, Inc. | 234 | 1 |
| LG Life Science LTD. | 235 | 1 |
| Lipocure Ltd. | 236 | 1 |
| LSK BioPartners, Inc. | 237 | 1 |
| Lupin Limited | 238 | 1 |
| Mabion SA | 239 | 1 |
| Mabtech Limited | 240 | 1 |
| mAbxience S.A. | 241 | 1 |
| MacroGenics, Inc. | 242 | 1 |
| Mebiopharm Co., Ltd. | 243 | 1 |
| MedAnnex Ltd | 244 | 1 |
| Medestea Research &Production S.p.A. | 245 | 1 |
| MediGene AG | 246 | 1 |
| MedImmune, LLC | 247 | 1 |
| Mesoblast Limited | 248 | 1 |
| Millennium Pharmaceuticals, Inc. | 249 | 1 |
| Mitsubishi Tanabe Pharma Corporation | 250 | 1 |
| Modern Biosciences Plc | 251 | 1 |
| ModiQuest Group | 252 | 1 |
| Momenta Pharmaceuticals, Inc. | 253 | 1 |
| Morphotek, Inc. | 254 | 1 |
| Mycenax Biotech Inc. | 255 | 1 |
| MYOS RENS Technology Inc. | 256 | 1 |
| Myungmoon pharmaceutical Co., Ltd. | 257 | 1 |
| NanoSmart Pharmaceuticals, Inc. | 258 | 1 |
| Navigen Pharmaceuticals, Inc. | 259 | 1 |
| Neovacs SA | 260 | 1 |
| Nimbus Therapeutics, LLC | 261 | 1 |
| Nissan Chemical Industries, Ltd. | 262 | 1 |
| Novartis AG | 263 | 1 |
| NovImmune SA | 264 | 1 |
| Nuevolution AB | 265 | 1 |
| Omeros Corporation | 266 | 1 |
| Oncobiologics, Inc. | 267 | 1 |
| Oncodesign SA | 268 | 1 |
| OncoImmune, Inc. | 269 | 1 |
| Ono Pharmaceutical Co., Ltd. | 270 | 1 |
| OPKO Health, Inc. | 271 | 1 |
| Opsona Therapeutics Limited | 272 | 1 |
| Oscotec Inc. | 273 | 1 |
| OSE Immunotherapeutics | 274 | 1 |
| Panacea Biotec Limited | 275 | 1 |
| Paras Biopharmaceuticals Finland Oy | 276 | 1 |
| Parvus Therapeutics, Inc. | 277 | 1 |
| Peptinov SAS | 278 | 1 |
| Pfenex Inc. | 279 | 1 |
| Pfizer Inc. | 280 | 1 |
| Pharmacyclics, Inc. | 281 | 1 |
| Pharmedartis GmbH | 282 | 1 |
| Phenex Pharmaceuticals AG | 283 | 1 |
| Philogen S.p.A. | 284 | 1 |
| PLx Pharma Inc. | 285 | 1 |
| Principia Biopharma Inc. | 286 | 1 |
| Progenra, Inc. | 287 | 1 |
| ProNoxis AB | 288 | 1 |
| ProtAb Ltd | 289 | 1 |
| Protagonist Therapeutics Inc. | 290 | 1 |
| Protalex, Inc. | 291 | 1 |
| Protalix BioTherapeutics, Inc. | 292 | 1 |
| Qu Biologics Inc. | 293 | 1 |
| R-Pharm | 294 | 1 |
| Re-Pharm Limited | 295 | 1 |
| ReceptoPharm, Inc. | 296 | 1 |
| RedHill Biopharma Ltd. | 297 | 1 |
| Redx Pharma Plc | 298 | 1 |
| Regeneron Pharmaceuticals, Inc. | 299 | 1 |
| Resverlogix Corp. | 300 | 1 |
| ReveraGen BioPharma, Inc. | 301 | 1 |
| Rhizen Pharmaceuticals S.A. | 302 | 1 |
| Richter Gedeon Nyrt. | 303 | 1 |
| Saje Pharma, LLC | 304 | 1 |
| Sandoz International GmbH | 305 | 1 |
| Sareum Holdings Plc | 306 | 1 |
| SBI Biotech Co., Ltd. | 307 | 1 |
| Selvita S.A. | 308 | 1 |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 309 | 1 |
| Shanghai Henlius Biotech Co., Ltd. | 310 | 1 |
| Shanghai Pharmaceutical Co., Ltd. | 311 | 1 |
| Swedish Orphan Biovitrum AB | 312 | 1 |
| Synovo GmbH | 313 | 1 |
| Syntrix Biosystems, Inc. | 314 | 1 |
| TaiwanJ Pharmaceuticals Co., Ltd. | 315 | 1 |
| Takeda Pharmaceutical Company Limited | 316 | 1 |
| TechnoPhage SA | 317 | 1 |
| Teijin Pharma Limited | 318 | 1 |
| The International Biotechnology Center (IBC) Generium | 319 | 1 |
| TheraMAB LLC | 320 | 1 |
| Therapeutic Proteins International, LLC | 321 | 1 |
| TiGenix NV | 322 | 1 |
| Toleranzia AB | 323 | 1 |
| Tumorend, LLC | 324 | 1 |
| TxCell SA | 325 | 1 |
| U.S. Stem Cell, Inc. | 326 | 1 |
| UCB S.A. | 327 | 1 |
| United BioPharma, Inc. | 328 | 1 |
| Vaccinex, Inc. | 329 | 1 |
| Valeant Pharmaceuticals International, Inc. | 330 | 1 |
| Vichem Chemie Research Ltd. | 331 | 1 |
| Vicore Pharma AB | 332 | 1 |
| Vida Therapeutics Inc. | 333 | 1 |
| Vitae Pharmaceuticals, Inc. | 334 | 1 |
| Vitaeris Inc | 335 | 1 |
| Xbrane Biopharma AB | 336 | 1 |
| Xencor, Inc. | 337 | 1 |
| XTL Biopharmaceuticals Ltd. | 338 | 1 |
| Yungjin Pharm. Co., Ltd. | 339 | 1 |
| Yuyu Pharma, Inc. | 340 | 1 |
| Zenyaku Kogyo Co., Ltd. | 341 | 1 |
| Zydus Cadila Healthcare Limited | 342 | 1 |
| Rheumatoid Arthritis Therapeutics Assessment | 343 | 34 |
| Assessment by Monotherapy Products | 343 | 1 |
| Assessment by Combination Products | 344 | 1 |
| Assessment by Target | 345 | 13 |
| Assessment by Mechanism of Action | 358 | 15 |
| Assessment by Route of Administration | 373 | 2 |
| Assessment by Molecule Type | 375 | 2 |
| Drug Profiles | 377 | 767 |
| (clarithromycin + clofazimine + rifabutin) Drug Profile | 377 | 7 |